Sponsor hub
Masonic Cancer Center, University of Minnesota clinical trial failures
Review 90 stopped clinical trials from Masonic Cancer Center, University of Minnesota, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 8 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OTHER/UNKNOWN
- 43
- OPERATIONAL
- 39
- SAFETY
- 7
- EFFICACY/FUTILITY
- 1
Notable sponsors
- Masonic Cancer Center, University of Minnesota
- 90
Related phases
- Phase II
- 48
- Phase I
- 30
- Unknown
- 10
- Early Phase I
- 1
- Phase III
- 1
Crawlable stopped-trial records
Open ExploreShowing up to 90 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Cerebral Adrenoleukodystrophy trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Awaiting supplies
Unknown Acute Myeloid Leukemia (AML) trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No longer a research question to answer.
Phase I Acute-graft-versus-host Disease trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Sponsor terminated financial support
Early Phase I Kava trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Drug expiration testing
Phase I DLBCL trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Accrual met
Phase I Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Product withdrawn from clinical development
Unknown Sickle Cell Disease trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another study
Phase I Lymphoma Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
replaced with a new IND and protocol
Phase I HIV-1-infection trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Abandoned
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow Accrual
Phase II Glioblastoma trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Change in approach to study.
Phase II Prostate Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Feasibility
Phase I Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome) trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Study went on hold because more pre-clinical work needs to be done per FDA feedback. However, the study never went off hold and the study team has decided to close this study without opening to enrollment.
Phase II Lung Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Because of logistic challenges and lack of product among other factors, we decided to completely withdrawn this study.
Unknown Acute Lymphoblastic Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Leukemia, Myeloid, Chronic trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
replaced by another study ; Trial re-written as MT2015-29
Unknown Maroteaux-Lamy Syndrome trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Germ Cell Tumor trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Funding Unavailable
Phase II Acute Lymphoblastic Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Considering new technology for product.
Phase II Kidney Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
IRB Study Closure
Phase I Diffuse Intrinsic Pontine Glioma trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Treatment ineffective; Extreme toxicity
Phase III Graft Versus Host Disease trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Terminated (due to no accrual)
Unknown Acute Leukemias trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another study.
Phase II Acute Lymphoblastic Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Drug was not available.
Phase I Fanconi Anemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Treatment with thymic shielding found safe, another study started.
Phase II Leukemia, Myeloid, Chronic trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Accrual Goal Met
Unknown Ovarian Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
PI Request
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II High-Risk Acute Myeloid Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Sponsor halted study.
Phase I Solid Tumors trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Funding unavailable
Phase II Lung Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Study has been abandoned for lack of available funding.
Phase I Metastatic Melanoma trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another study.
Phase II Hemophagocytic Lymphohistiocytosis trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another protocol
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
slow accrual
Phase II Pancreatic Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Funding not available
Phase II Fallopian Tube Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Study was terminated due to lack of available funding.
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Met protocol stop rule \[i.e., extreme toxicity\]
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Unknown Epidermolysis Bullosa trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Competing studies
Phase II Fallopian Tube Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Withdrawn due to toxicity
Phase I Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: EFFICACY/FUTILITY.
Lack of efficacy after interim analysis
Phase I Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Low accrual
Unknown Hematopoietic Stem Cell Transplant trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Lack of patients and no longer influenza vaccine season.
Phase II Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another protocol
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Unable to recruit further patients.
Phase II Histiocytosis, Langerhans-cell trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Acute Lymphoblastic Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Lung Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Due to drug unavailability
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Competing study was started.
Phase II Leukemia, Myelogenous, Acute trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
study drug (Ontak) no longer available
Phase II Osteopetrosis trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Excess toxicity
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Due to graft failure.
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Due to slow accrual of patients
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Withdrawn due to toxicity
Phase I Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
PI left institution.
Phase II Hurler's Syndrome trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another study
Phase II Acute Myelogenous Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase I Fallopian Tube Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
lack of funding
Phase I Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No patients exhibited natural killer cell expansion (primary endpoint).
Phase II Pancreatic Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
Closed at a planned interim analysis by meeting a predefined toxicity endpoint
Phase II Head and Neck Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Low dose radiation treatment was not appropriate for these patients.
Phase I Acute Myelogenous Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Leukemia, Lymphocytic, Acute trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by a different study
Phase I Brain and Central Nervous System Tumors trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by another study
Phase II Acute Myeloid Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
IRB Disapproval
Phase II Lymphoproliferative Disorder trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Funding unavailable
Phase II Multiple Myeloma trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Acute Myeloid Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to no accrual
Phase I Graft Versus Host Disease trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Hematologic Malignancies trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Changing study design. Will replace with a different protocol.
Phase I Hematologic Malignancy trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced by a new study
Phase I Cerebral Adrenoleukodystrophy trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Research cancelled
Phase II Acute Myelogenous Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: SAFETY.
study was abandoned and a new study was written to replace this one
Phase I Fallopian Tube Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to low accrual
Phase I Germ Cell Tumor trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual
Phase II Multiple Myeloma and Plasma Cell Neoplasm trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Withdrawn because treatment guidelines changed
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Principal investigator left the university.
Phase II Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Study terminated as principal investigator \[PI\] left the university.
Phase I Brain and Central Nervous System Tumors trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to slow accrual
Unknown Chronic Myeloproliferative Disorders trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced with another study
Phase II Metastatic Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to slow accrual
Phase I Lung Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Funding and study drugs unavailable
Phase I Cervical Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to lack of accrual
Phase I Graft Versus Host Disease trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Slow accrual.
Phase I Lung Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OPERATIONAL.
Withdrawn due to lack of accrual
Phase I Breast Cancer trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Leukemia trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Replaced with another study
Phase II Lymphoma trial by Masonic Cancer Center, University of Minnesota. Stop reason: OTHER/UNKNOWN.
Withdrawn because study never enrolled patients